Aptorum Group Limited (NASDAQ:APM) Short Interest Update

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 18,900 shares, an increase of 44.3% from the November 15th total of 13,100 shares. Based on an average daily trading volume, of 41,800 shares, the short-interest ratio is presently 0.5 days. Currently, 0.9% of the shares of the stock are short sold.

Aptorum Group Price Performance

Shares of NASDAQ:APM traded up $0.01 during trading on Friday, hitting $0.77. The company had a trading volume of 11,128 shares, compared to its average volume of 653,215. The company has a fifty day simple moving average of $1.21 and a two-hundred day simple moving average of $2.70. Aptorum Group has a one year low of $0.46 and a one year high of $17.49.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.